Transcript Slide 1

nanoDLSA: A Novel Homogeneous Immunoassay for Biomarker Detection using
Gold Nanoparticles Coupled with Dynamic Light Scattering Detection
NanoScience
Technology Center
Xiong Liu, Qiu Dai, Lauren Austin, Janelle Coutts, Genevieve Knowles, Jianhua Zou, Hui Chen, Qun Huo*
Nanoscience Technology Center, Department of Chemistry, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826
Email: [email protected], Tel: 407-882-2845, Fax: 407-882-2819.
Why gold nanoparticles?
Key Features:
What’s new for cancer biomarker early detection and
diagnosis?
40 nm GNP
 Strong Light Scattering Properties
 4~5 orders higher than proteins in
solutions
 High absorption efficacy at SPR
50 nm
band
 Biocompatible
 Photothermal conversion properties 40 nm by 10 nm GNR
 Ultra-sensitive detection in DLS
 GNP: 0.02 pM
 GNR: 0.4 pM
60 nm
Figure 1. dynamic light scattering intensities and linear regression curves of gold nanospheres (GNP)
and gold nanorods.
I  D3
 Trace Brownian motion of particles in solution
 Measure diffusion constants of particles in solution
after Fast Fourier Transform (FFT)
 Decoding of hydrodynamic diameter information of
particles by Stokes-Einstein Equation.
Traditional Use: Qualitative
 Protein size measurement (>1 ug/mL)
 Trace for Protein aggregates and glycoprotien
formation for proteins and drugs
Figure 2. UV-Vis spectra of gold nanoparticles and gold nanorods and their conjugates with primary
antibodies: (a) citrate-protected gold nanoparticles (GNP); (b) f-PSA detector antibody conjugated gold
nanoparticles (GNP-dAb); (c) CTAB-protected gold nanorods (GNR); and (d) f-PSA capture antibody
conjugated gold nanorods (GNR-cAb).
New Feature: Quantitative, Ultra-Sensitive
High Sensitivity for Aggregates
 Three order of magnitude more sensitive in
aggregates formation than individual particles
ID
 To trace cancer biomarker levels in pg/mL range
 Significant amplification of signal with
nanotechnology-embedded probes.
a
b
3
 Detector antibody- GNPs
 Capture antibody- GNRs
 Size increase from surface antibody layer
was monitored by DLS
 GNP Nanoprobe: 56.7 nm
 GNR Nanoprobe: 37.2 nm
 After mixed, ready for immunoassay
The Reaction
 Biomarkers initialize sandwich
of GNP and GNR
 Cross-link due to multiple
antibodies on nanoprobes
 Reaction induce
hydrodynamic diameter increase
of nanoprobes
 More biomarker, more
oligomers, higher numerical ratio
a
b
Immunoassay
 free-prostate specific antigen
 Assay range: 0-10 ng/mL
 Increasing tendency observed
 Sensitivity better than ELISA
 Specificity verified
Key Advantages
Conjugation of Antibodies to
Nanoprobes
c
d
Acknowledgement: National Science Foundation CAREER award DMR 0552294 and NIRT award 0506531.
Figure 3. TEM micrographs of: (a-c) nanoparticle oligomers formed from a mixture of primary
antibodies conjugated gold nanoparticles and gold nanorods with the addition of f-PSA antigens (2
ng/mL) in the mixed nanoprobe solution; and (d-f) same nanoparticle oligomers, but with additional
conjugations of 2nd antibody-coated 5 nm gold nanoparticles to the oligomers (Scale bar: 20 nm,
except for d, which is 10 nm).
Figure 4. DLS analysis data of individual
nanoprobes and nanoprobe oligomers
formed with the addition of free-PSA
antigens at different concentrations.
Dynamic Light Scattering Detector
 Gold nanospheres: 532 nm
 Gold nanorods: 520 nm and 730
nm
 Red-shift of bands after antibody
conjugation indicated successful
conjugation process
 Dimmer, trimmer, tetramer and oligomers for GNP and GNR pairs visualized by HRTEM
 Conjugation activity was further verified by 2oAb-conjugated 5 nm GNPs
 Mix of biomarker solution with
nanoprobes solution and incubate
 Measurement of Sizes and Size
Distributions of nanoprobes and
their oligomers by DLS
 Analysis and processing of data
 Numerical ratio of oligomers
over individual nanoprobes
obtained
 Different biomarker
concentration shows different ratio
 Level of biomarker message
presented
A one-step homogeneous immunoassay for the detection of a
prostate cancer biomarker, free-PSA (Prostate Specific Antigen), was
developed using gold nanoparticle probes coupled with dynamic light
scattering (DLS) measurements due to their orders of magnitude stronger
light scattering properties. A spherical gold nanoparticle (GNP) and a gold
nanorod (GNR) were first conjugated with two different primary antibodies
and then used as optical probes for the immunoassay. In the presence of
antigen f-PSA in solution, the nanoparticles and nanorods aggregate
together into pairs and oligomers through the formation of a sandwich type
antibody-antigen-antibody linkage. The relative ratio of nanoparticlenanorod pairs and oligomers versus individual nanoparticles was
quantitatively monitored by DLS measurement. A correlation can be
established between this relative ratio and the amount of antigen in
solution. f-PSA in the concentration range from 0.1 to 10 ng/mL was
detected by this one-step and washing-free homogeneous immunoassay.
Surface Plasmon
Resonance
Direct View of Reaction: Oligomers
How it works?
References:
• Liu, X.; Dai Q.; Austin, L.; Coutts, j.; Knowles, G.; Zou, J.; Chen, H.; Huo, Q. A one-step homogenesou immunoassay for
cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J. Am. Chem. Soc.
2008,130, 2780-2782.
• Liu, X.; Atwater, M.; Wang, J.; Huo, Q. Extinction coefficient of gold nanoparticles with different sizes and different capping
ligands. Colloids and Surface B: Biointerfaces 2007, 58, 3-7.
 High sensitivity: pg/mLto ng/mL
range
 Washing free- versus multiple
washing and incubation in ELISA
 Homogeneous- much better
reactivity
 Fast- 15 minutes for assay is
reachable
 Extremely small sample volume:
1~2 uL- save precious blood fluids
c
Figure 5. The calculated numerical ratio of nanoprobe aggregates over
individual nanoprobes as determined by DLS measurements: (a) 1:2.5
mixture of GNP-dAb:GNR-cAb in the presence of f-PSA 1.0 ng/mL; (b)
measurements at different f-PSA level (the unknown sample has a
concentration of 0.5 ng/ml, data labeled with an asterisk) and (c) specificity
and cross reactivity test with biomarker CA125.